Huhle, G <br/><br/>
Anti-r-hirudin antibodies reveal clinical relevance through direct functional inactivation of r-hirudin or prolongation of r-hirudin's plasma halflife.  [electronic resource] 

 -  Thrombosis and haemostasis  May 2001 
 - 936-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--blood<br/>Antibody Affinity<br/>Antithrombins--administration & dosage<br/>Female<br/>Half-Life<br/>Hirudin Therapy<br/>Hirudins--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Recombinant Proteins--administration & dosage<br/>Thrombocytopenia--chemically induced